BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2016
View Archived Issues
XT-150 as a potential solution for opioid abuse crisis
Read More
Array BioPharma and Asahi Kasei Pharma establish strategic collaboration in pain and inflammation
Read More
Morphotek and AREVA Med to investigate ontuxizumab conjugated with lead-212
Read More
Astellas announces a new collaborative research agreement with AIST
Read More
Astellas and LEO Pharma announce the closing of transaction to transfer global dermatology business
Read More
Janssen discontinues phase III development of fulranumab for osteoarthritis pain
Read More
Guizhou Bailing Group Pharmaceutical discloses alpha-glucosidase inhibitors
Read More
Active Biotech patents S100A9 inhibitors
Read More
Bristol-Myers Squibb presents peroxidase inhibitors
Read More
Eli Lilly develops PDE4B inhibitors
Read More
Calreticulin antibody useful in the assessment of bone marrow biopsies
Read More
Array BioPharma discontinues MILO study of binimetinib
Read More
Amicus' migalastat gets positive opinion from EMA for Fabry disease
Read More
EMA's CHMP backs approval of Trevicta for schizophrenia
Read More
Samsung Bioepis' infliximab biosimilar receives positive opinion in E.U.
Read More
Positive interim results obtained in phase III trial of masitinib in ALS
Read More
CHMP recommends approval of Strimvelis for ADA-SCID
Read More
BMS's acquisition of Padlock Therapeutics completed
Read More
Xilonix will undergo accelerated assessment in E.U.
Read More
APE1 and MTH1 may be useful biomarkers for the diagnosis of breast cancer
Read More
IXICO announces two milestones concerning its Parkinson's disease franchise
Read More
Meiji Seika Pharma receives marketing rights for Ultibro and Seebri from Novartis Pharma in Japan
Read More
EMA committee recommends approval of pandemic influenza vaccine
Read More
Bionomics begins phase I trial for BNC-101 in metastatic colorectal cancer
Read More
CHMP supports E.U. approval of daratumumab
Read More
Acetylon Pharmaceuticals reports HDAC6 inhibitors
Read More
New bromodomain inhibitor shows promising preclinical results
Read More